Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体
This anti-PDCD1 (Pembrolizumab Biosimilar) antibody (ABIN7487773) is a Mammalian Cells Monoclonal antibody detecting PDCD1 (Pembrolizumab Biosimilar) in ELISA. Suitable for Human.
Quick Overview for Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体 (ABIN7487773)
抗原
PDCD1 (Pembrolizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This PDCD1 (Pembrolizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Pembrolizumab Biosimilar - Anti-PD1 mAb
-
产品特性
- Antibody Type: IgG4
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4
-
-
anti-PDCD1 (Pembrolizumab Biosimilar) antibody
Research Grade 适用: 人 FACS, ELISA 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C for short term, -20°C for long term
-
-
- PDCD1 (Pembrolizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Pembrolizumab
Pembrolizumab is a humanized (from mouse) monoclonal antibody that binds to, and blocks PD-1 located on lymphocytes. It is an anticancer medication used in the treatment of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, urothelial cancer (cancer of the bladder and urinary tract) and renal cell carcinoma (kidney cancer).
抗原
-
You are here:
